Jennifer R. Cochran, PhD, Associate Professor, Department of Bioengineering, and (by courtesy) Chemical Engineering, Stanford University School of Engineering
Research Description: Dr. Cochran’s laboratory uses interdisciplinary approaches in chemistry, biology, and engineering to develop novel peptides and proteins that can be used as research tools or as therapeutic candidates for treating human disease. True to the spirit and culture of Stanford, we are highly collaborative across multiple departments and schools both within and outside the university and hospital. Several of the engineered proteins from our lab are undergoing further clinical/translational development through collaborations with clinicians and physician-scientists in the Stanford School of Medicine. While Dr. Cochran is an established researcher, she is new to diabetes research. She was recently awarded a Stanford Diabetes Research Center Pilot and Feasibility Grant to develop novel agonists of the glucagon-like peptide-1 receptor (GLP-1R) with improved potency and unique pharmacological properties that will be used as research tools and as potential therapeutic candidates. This grant presents an exciting opportunity for her group to bring tools and technologies to the field and establish new collaborations in diabetes research, precisely aligned with the mission of the Stanford DRC.